Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.

By Z. Fang, Johannes B. Prins, Thomas H. Marwick. Endocrine reviews, 2004

952 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/d6c045a00c03e479fd948de8c21acd99ec35c77c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Guanghong Jia
2. J. Sowers
3. J. Forbes
4. M. Cooper

Citations in the corpus

• Epidemiology of Sudden Cardiac Death: Clinical and Research Implications (2008, background): “In the literature, a case is being made for the existence of a distinct form of cardiac dysfunction that has been termed “diabetic cardiomyopathy” (58,59).”
• Mechanisms of diabetic complications. (2013, background): “Diabetic cardiomyopathy is also improved by targeting GLUT-4 transporters (173).”
• Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease (2017, background): “These collective metabolic disturbances promote cardiac remodelling, fibrotic diastolic dysfunction and, ultimately, decreased ejection fraction in those with diabetes [14, 15].”